The annual PDA Global Conference on Pharmaceutical Microbiology continues to address the most relevant challenges and opportunities impacting the future of quality control microbiology today. Join new and seasoned professionals from all facets of microbiology, including industry, academia, and regulatory authorities, to share insights on how to best prepare for the future through sharing best practices, developing industry standards, and integrating innovative technologies.
As part of the agenda, our Microbial Solutions team will be featuring the following content:
Importance of Strain Diversity in the Identification of Fungi by MALDI-TOF Mass Spectrometry | Komal Iqbal, Research Associate
A Robust Validation Strategy for Implementing a New Microbial Identification System | Jessica J. Rayser, Sr. Product Manager
We will also have the following Tech Talk during the event:
Application of Next Generation Sequencing for Microbial Identification Typing and Profiling | Dr. Prasanna Khot, Research & Development Manager
We would also encourage attendees to watch the following presentations:
Monday, October 4
1:25 PM: Implementing a Rapid Sterility Method: How We Went from Bold Idea to Completed Project at Lightspeed | Joanny Salvas, Senior Manager, Pfizer
1:45 PM: The Next Phase: A Framework for Multi-Product Adoption of Rapid Sterility Testing | Miriam Guest, Associate Principal Microbiologist, AstraZeneca
Tuesday, October 5
1:30 PM: Implementing the QC Lab of the Future Today: Automating Endotoxin Testing for Water and Buffer Samples | Aude Smeets, PhD, Analytical Technical Expert, GSK
Stop by our exhibit in the virtual platform to see our showcase of products and services we have available to help support your program and expedite your time to market. If you’d like to set up a dedicated time for a meeting, please complete the following form.